Manufacturer or GPO Program year 2025 Source: CMS Open Payments

NovApproach Spine, LLC

FL, United States

CMS manufacturer 100001176931

Open in the dashboard

General payments

$217,623

301 payments

Research payments

$0

0 payments

Ownership & investment interest

$33,894,254

101 holdings by physicians or their families

Through program year 2025, NovApproach Spine, LLC reported paying $217,623 in general payments and $0 in research payments to U.S. physicians, teaching hospitals and other recipients.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $51,655 65
2024 General $88,354 178
2023 General $37,582 54
2022 General $40,032 4

Breakdown

Top recipients General payments · program year 2025
  1. Michael MacMillan Orthopaedic Surgery · Gainesville, FL $16,351 14 payments
  2. Erich Richter Neurological Surgery · Saginaw, MI $16,325 3 payments
  3. Thomas Terramani Vascular Surgery · La Mesa, CA $6,643 8 payments
  4. Timothy Rasmusson Surgery · Kenmore, NY $3,236 5 payments
  5. Jeffrey Wang Orthopaedic Surgery of the Spine · Los Angeles, CA $2,807 4 payments
  6. John Liu Neurological Surgery · Los Angeles, CA $2,250 3 payments
  7. Jonathan Gottlieb Orthopaedic Surgery of the Spine · Coral Gables, FL $1,197 3 payments
  8. Franco Vigna Orthopaedic Surgery of the Spine · Niagara Falls, NY $250 1 payment
  9. Patrick Dermarkarian Orthopaedic Surgery · Bradenton, FL $250 1 payment
  10. Racheal Peterson Neurological Surgery · Ocala, FL $240 1 payment
Products the payments named General payments · program year 2025
  1. OneLIF Orthopedics/Orthopedic Surgery $51,655 100% · 29 recipients

Each share is of this company’s general payments naming a product in 2025. A payment can name up to five products, so these amounts overlap.

Specialties paid General payments · program year 2025
  1. Neurological Surgery $19,345 38% · 9 practitioners
  2. Orthopaedic Surgery $16,770 33% · 4 practitioners
  3. Vascular Surgery Surgery $6,643 13% · 1 practitioner
  4. Orthopaedic Surgery of the Spine Orthopaedic Surgery $5,277 10% · 11 practitioners
  5. Surgery $3,236 6% · 1 practitioner

The top 5 of 7 specialties; each share is of this company’s general payments to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Florida $18,261 35% · 6 recipients
  2. Michigan $16,504 32% · 3 recipients
  3. California $11,736 23% · 4 recipients
  4. New York $3,559 7% · 3 recipients
  5. Texas $568 1% · 5 recipients

The top 5 of 10 states; each share is of this company’s general payments in 2025 where a state was reported.

The top 25 states, free in the app

What the payments were for General payments · program years 2022–2025
  1. Consulting Fee $176,211 97 payments
  2. Royalty or License $18,624 16 payments
  3. Travel and Lodging $14,888 52 payments
  4. Food and Beverage $7,900 136 payments
301 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers of drugs, devices and biologicals, and group purchasing organisations, are required to report the payments and transfers of value they make to physicians and teaching hospitals. This page shows what this company reported.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record